High intratumoral dihydropyrimidine dehydrogenase mRNA levels in pancreatic cancer associated with a high rate of response to S-1

Cancer Chemotherapy and Pharmacology

Volumn 63, Issue 1, 2008, Pages 85-89

  Kuramochi, Hidekazu ^a   Hayashi, Kazuhiko ^a   Uchida, Kazumi ^a   Nakajima, Go ^a   Hatori, Takashi ^a   Danenberg, Kathleen D ^b   Danenberg, Peter V ^c   Yamamoto, Masakazu ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b Response Genetics Inc   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

DPD; Gene expression; Pancreatic cancer; S 1

Indexed keywords

5 CHLORO 2,4 DIHYDROXYPYRIDINE PLUS OXONATE POTASSIUM PLUS TEGAFUR; BETA ACTIN; CA 19-9 ANTIGEN; CISPLATIN; DIHYDROPYRIMIDINE DEHYDROGENASE; MESSENGER RNA; THYMIDYLATE SYNTHASE;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CHEMOSENSITIVITY; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MALE; NUCLEOTIDE SEQUENCE; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; TREATMENT RESPONSE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CA-19-9 ANTIGEN; CISPLATIN; COLORECTAL NEOPLASMS; DIHYDROURACIL DEHYDROGENASE (NADP); DRUG COMBINATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; OXONIC ACID; PANCREATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; STOMACH NEOPLASMS; TEGAFUR; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 53149090560     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-008-0714-x     Document Type: Article

References (27)

1. Anonymous (1992) Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-analysis Project. J Clin Oncol 10:896-903
2. DP Baccanari ST Davis VC Knick T Spector 1993 5-Ethynyluracil (776C85): a potent modulator of the pharmacokinetics and antitumor efficacy of 5-fluorouracil Proc Natl Acad Sci U S A 90 11064 11068
3. HA Burris 3rd MJ Moore J Andersen MR Green ML Rothenberg MR Modiano MC Cripps RK Portenoy AM Storniolo P Tarassoff R Nelson FA Dorr CD Stephens DD Von Hoff 1997 Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial J Clin Oncol 15 2403 2413
4. J Crown ES Casper J Botet P Murray DP Kelsen 1991 Lack of efficacy of high-dose leucovorin and fluorouracil in patients with advanced pancreatic adenocarcinoma J Clin Oncol 9 1682 1686
5. S Cullinan CG Moertel HS Wieand AJ Schutt JE Krook JF Foley BD Norris CG Kardinal LK Tschetter JF Barlow 1990 A phase III trial on the therapy of advanced pancreatic carcinoma. Evaluations of the Mallinson regimen and combined 5-fluorouracil, doxorubicin, and cisplatin Cancer 65 2207 2212
6. A de Gramont JF Bosset C Milan P Rougier O Bouche PL Etienne F Morvan C Louvet T Guillot E Francois L Bedenne 1997 Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study J Clin Oncol 15 808 815
7. JA DeCaprio RJ Mayer R Gonin SG Arbuck 1991 Fluorouracil and high-dose leucovorin in previously untreated patients with advanced adenocarcinoma of the pancreas: results of a phase II trial J Clin Oncol 9 2128 2133
8. B Glimelius K Hoffman W Graf L Pahlman PO Sjoden 1994 Quality of life during chemotherapy in patients with symptomatic advanced colorectal cancer. The Nordic Gastrointestinal Tumor Adjuvant Therapy Group Cancer 73 556 562
9. R Hansen E Quebbeman P Ritch C Chitambar T Anderson 1988 Continuous 5-fluorouracil (5FU) infusion in carcinoma of the pancreas: a phase II study Am J Med Sci 295 91 93
10. K Hayashi T Imaizumi K Uchida H Kuramochi K Takasaki 2002 High response rates in patients with pancreatic cancer using the novel oral fluoropyrimidine S-1 Oncol Rep 9 1355 1361
11. CA Heid J Stevens KJ Livak PM Williams 1996 Real time quantitative PCR Genome Res 6 986 994
12. K Hirata N Horikoshi K Aiba M Okazaki R Denno K Sasaki Y Nakano H Ishizuka Y Yamada S Uno T Taguchi T Shirasaka 1999 Pharmacokinetic study of S-1, a novel oral fluorouracil antitumor drug Clin Cancer Res 5 2000 2005
13. W Ichikawa T Takahashi K Suto T Yamashita Z Nihei Y Shirota M Shimizu Y Sasaki R Hirayama 2004 Thymidylate synthase predictive power is overcome by irinotecan combination therapy with S-1 for gastric cancer Br J Cancer 91 1245 1250
14. S Kamoshida K Shiogama R Shimomura K Inada Y Sakurai M Ochiai H Matuoka K Maeda Y Tsutsumi 2005 Immunohistochemical demonstration of fluoropyrimidine- metabolizing enzymes in various types of cancer Oncol Rep 14 1223 1230
15. H Kuramochi K Hayashi K Uchida S Miyakura D Shimizu D Vallbohmer S Park KD Danenberg K Takasaki PV Danenberg 2006 5-fluorouracil-related gene expression levels in primary colorectal cancer and corresponding liver metastasis Int J Cancer 119 522 526
16. RV Lord D Salonga KD Danenberg JH Peters TR DeMeester JM Park J Johansson KA Skinner P Chandrasoma SR DeMeester CG Bremner PI Tsai PV Danenberg 2000 Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, adenocarcinoma sequence J Gastrointest Surg 4 135 142
17. K Mori M Hasegawa M Nishida H Toma M Fukuda T Kubota N Nagasue H Yamana YSCK Hirakawa T Ikeda K Takasaki M Oka M Kameyama M Toi H Fujii M Kitamura M Murai H Sasaki S Ozono H Makuuchi Y Shimada Y Onishi S Aoyagi K Mizutani M Ogawa A Nakao H Kinoshita T Tono H Imamoto Y Nakashima T Manabe 2000 Expression levels of thymidine phosphorylase and dihydropyrimidine dehydrogenase in various human tumor tissues Int J Oncol 17 33 38
18. G Nishimura S Yanoma H Mizuno K Satake T Taguchi Y Ikeda M Tsukuda 2000 Therapeutic effect of 1 M tegafur-0.4 M 5-chloro-2, 4-dihydroxypridine-1 M potassium oxonate (S-1) on head and neck squamous carcinoma cells Cancer Lett 159 1 7
19. SS Nitecki MG Sarr TV Colby JA van Heerden 1995 Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann Surg 221 59 66
20. A Ohtsu H Baba Y Sakata Y Mitachi N Horikoshi K Sugimachi T Taguchi 2000 Phase II study of S-1, a novel oral fluorophyrimidine derivative, in patients with metastatic colorectal carcinoma. S-1 Cooperative Colorectal Carcinoma Study Group Br J Cancer 83 141 145
21. MA Poon MJ O'Connell CG Moertel HS Wieand SA Cullinan LK Everson JE Krook JA Mailliard JA Laurie LK Tschetter 1989 Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma J Clin Oncol 7 1407 1418
22. T Saek S Takashima M Sano N Horikoshi S Miura S Shimizu K Morimoto M Kimura H Aoyama J Ota S Noguchi T Taguchi 2004 A phase II study of S-1 in patients with metastatic breast cancer-a Japanese trial by the S-1 Cooperative Study Group, Breast Cancer Working Group Breast Cancer 11 194 202
23. Y Sakata A Ohtsu N Horikoshi K Sugimachi Y Mitachi T Taguchi 1998 Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1 M tegafur-0.4 M gimestat-1 M otastat potassium) in advanced gastric cancer patients Eur J Cancer 34 1715 1720
24. T Shirasaka Y Shimamato H Ohshimo M Yamaguchi T Kato K Yonekura M Fukushima 1996 Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators Anticancer Drugs 7 548 557
25. T Takechi A Fujioka E Matsushima M Fukushima 2002 Enhancement of the antitumour activity of 5-fluorouracil (5-FU) by inhibiting dihydropyrimidine dehydrogenase activity (DPD) using 5-chloro-2,4-dihydroxypyridine (CDHP) in human tumour cells Eur J Cancer 38 1271 1277
26. K Tatsumi M Fukushima T Shirasaka S Fujii 1987 Inhibitory effects of pyrimidine, barbituric acid and pyridine derivatives on 5-fluorouracil degradation in rat liver extracts Jpn J Cancer Res 78 748 755
27. H Uetake W Ichikawa T Takechi M Fukushima Z Nihei K Sugihara 1999 Relationship between intratumoral dihydropyrimidine dehydrogenase activity and gene expression in human colorectal cancer Clin Cancer Res 5 2836 2839